Increasing pet adoption and healthcare expenditure are fueling adoption of veterinary diagnostic solutions for preventive disease detection and early disease detection. Government programs for animal health monitoring and livestock disease surveillan... Explore Report »
Research Reports in Healthcare
Showing 10 results in Healthcare
Increasing demand for precision medicine is driving the demand for targeted DNA/RNA sequencing. Rising cancer prevalence across the world propels the growth of the market. High cost and intensive process for assay design hinder the market expansion. ... Explore Report »
Rising incidence of chronic conditions drives the demand for transdermal drug delivery systems. Increasing aging population prone to chronic disease fuels the growth of the market. Regulatory and compliance requirements hinder the market expansion. T... Explore Report »
Pet ownership is on the rise and owners are seeking early diagnosis and treatment. This is driving demand for veterinary renal disease care. Progress in veterinary diagnostics and treatment options is helping market growth as new technologies enhance... Explore Report »
The growing prevalence of varicose veins, especially among aging populations, is a major driver of market growth. The market is witnessing a shift towards minimally invasive treatments due to their ability to offer effective results with minimal down... Explore Report »
Rare disease genetic testing is used to examine a person's DNA. The testing helps identify genetic changes linked to rare diseases. It helps clinicians understand the cause of a condition and confirm diagnosis. The testing assist in making effective ... Explore Report »
The term multiomics in drug discovery is used to describe a scientific study where biological information coming from more than one biological layer, such as genomics, transcriptomics, proteomics, and metabolomics, is combined to learn about disease ... Explore Report »
The semaglutide market is the global pharmaceutical industry focused on the development, manufacturing, and commercialization of semaglutide-based GLP-1 receptor agonist drugs used to treat type 2 diabetes and obesity. These medications work by regul... Explore Report »
Lysosomal storage disease treatment includes therapies used to manage inherited metabolic disorders caused by missing or defective lysosomal enzymes. These treatments include enzyme replacement therapy, substrate reduction therapy, stem cell therapy,... Explore Report »
Natural language processing extracts insights from clinical records. AI correlates patient symptoms with genetic information. Automated genome analysis reduces diagnostic turnaround time. AI tools enable early detection of rare genetic disorders. The... Explore Report »